PREconception weight management Programme to Achieve weight Reduction and Enhance fertility (PREPARE)
Key facts
- Where
- Dublin 4, ÍrországSee the site
- Phase
- 4. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Írország
- St Vincent's University HospitalDublin 4, ÍrországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University College Dublin
- Trial code
- EU 2026-526869-19-00
- Record updated
- 2026. október 30.
- Original description
The primary objective is to assess the feasibility and acceptability of combining pharmacotherapy with a digitally delivered behaviour change intervention, compared with behaviour change alone, to support weight loss and improve fertility in women living with obesity and infertility.Read full original descriptionShow less
A feasibility randomised controlled trial of a weight management programme for women living with obesity and infertility
The primary objective is to assess the feasibility and acceptability of combining pharmacotherapy with a digitally delivered behaviour change intervention, compared with behaviour change alone, to support weight loss and improve fertility in women living with obesity and infertility.
Inclusion: Women aged 18-39 years; BMI 30-40 kg/m2; Trying to conceive for > 12 months if under 36 years of age, or for > 6 months if aged 36 years of age or over and have had fertility assessments completed within the previous 6 months; Meet the following HSE criteria for fertility treatment; Agreeable to contraceptive use if allocated to the intervention group; Meet study eligibility criteria; Willing and able to give informed consent.
Exclusion: Concurrent participation in another investigational medicinal product study, although participants will not be excluded from other observational studies provided the other observational studies have no interventions; Known hypersensitivity or contraindication to the intervention medication; Current pregnancy or breastfeeding; Unwilling or unable to give informed consent.